莱美药业(300006.SZ)：注射用氨曲南获得药品补充申请批准通知书

Core Viewpoint - Lai Mei Pharmaceutical has received approval from the National Medical Products Administration for the injection of Aztreonam (0.5g), which is indicated for the treatment of infections caused by sensitive Gram-negative bacteria [1] Group 1 - The approved drug, Aztreonam, is suitable for treating various infections, including urinary tract infections (both uncomplicated and complicated), lower respiratory tract infections, sepsis, skin and skin structure infections, intra-abdominal infections, and gynecological infections [1]